Premium
Navigating increasingly individualised Hodgkin lymphoma treatments to optimally balance risks and benefits
Author(s) -
Bröckelmann Paul J.,
Borchmann Peter
Publication year - 2022
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.18130
Subject(s) - abvd , medicine , dacarbazine , vinblastine , hodgkin's lymphoma , guideline , radiation therapy , stage (stratigraphy) , disease , oncology , brentuximab vedotin , hodgkin lymphoma , lymphoma , intensive care medicine , chemotherapy , vincristine , pathology , paleontology , biology , cyclophosphamide
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom